✦ LIBER ✦

PSS20 Cost-Utility Analysis of Treatments for Macular Edema Secondary to Retinal Vein Occlusion

✍ Scribed by Duff, S.; Gricar, J.; Kymes, S.; Tran, I.; Turpcu, A.; Sternberg, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSS13 INCREMENTAL COST-UTILITY ANALYSIS

✍ J. Kowalski; W.S. Yeh; B. O'Leary; S. Ackerman; S. Sharma; M. Adena 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PSS18 Ranibizumab for the Treatment of M

✍ Taylor, M.; Serbetci, E.; Ferreira, A.; Gairy, K.; Blouin, J.; Mitchell, P.; Lew 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Intravitreal Ranibizumab for Macular Ede

✍ Kim, Moosang; Yu, Seung-Young; Kim, Eung-Suk; Bae, So Hyun; Park, Jung Hyun; Yu, 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 198 KB

Pegaptanib Sodium for Macular Edema Seco

✍ John J. Wroblewski; John A. Wells III; Christine R. Gonzales 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 863 KB

Multiple laser treatments for macular ed

✍ Erica Esrick; Manju L. Subramanian; Jeffrey S. Heier; Anand K. Devaiah; Trexler 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Bevacizumab for Macular Edema Secondary

✍ Lu, Yi; Su, Li; Xu, Xun 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 675 KB